THREE-DIMENSIONAL PLANNING OF BRACHYTHERAPY FOR LOCALLY ADVANCED CERVICAL CANCER BY CT/MRI IMAGES
PDF (Русский)

Keywords

3D ПЛАНИРОВАНИЕ КТ/МРТ
CERVIX CANCER
INTRACAVITARY RADIOTHERAPY
BRACHYTHERAPY
3D CT/MRI PLANNING

How to Cite

Kravets, O., Romanova, Y., Kozlov, O., Nechushkin, M., Gavrilova, A., & Belova, A. (2018). THREE-DIMENSIONAL PLANNING OF BRACHYTHERAPY FOR LOCALLY ADVANCED CERVICAL CANCER BY CT/MRI IMAGES. Voprosy Onkologii, 64(5), 645–650. https://doi.org/10.37469/0507-3758-2018-64-5-645-650

Abstract

We present our results of 3D CT/MRI brachytherapy (BT) planning in 115 patients with locally advanced cervical cancer T2b-3bN0-1M0. The aim of this study was to assess the differences in the visualization of tumor target volumes and risk organs during the 3D CT/MRI BT. The results of the study revealed that the use of MRI imaging for dosimetric planning of dose distribution for a given volume of a cervical tumor target was the best method of visualization of the soft tissue component of the tumor process in comparison with CT images, it allowed to differentially visualize the cervix and uterine body, directly the tumor volume. Mean D90 HR-CTV for MRI was 32.9 cm3 versus 45.9 cm3 for CT at the time of first BT, p = 0.0002, which is important for local control of the tumor process. The contouring of the organs of risk (bladder and rectum) through MRI images allows for more clearly visualizing the contours, which statistically significantly reduces the dose load for individual dosimetric planning in the D2cc control volume, і.є. the minimum dose of 2 cm3 of the organ of risk: D2cc for the bladder was 24.3 Gy for MRI versus 34.8 Gy on CT (p = 0.045); D2cc for the rectum - 18.7 Gy for MRI versus 26.8 Gy for CT (p = 0.046). This is a prognostically important stage in promising local control, which allows preventing manifestation of radiation damage.
https://doi.org/10.37469/0507-3758-2018-64-5-645-650
PDF (Русский)

References

Моисеенко В.М. Практические рекомендации по лекарственному лечению злокачественных опухолей (RUSSCO) // В.М. Моисеенко и соавт. - М.: Общество онкологов-химиотерапевтов. - 2014. - С. 138-146.

Chargari C., Magné N., Dumas I. et al. Physics contributions and clinical outcome with 3D-MRI-based pulsed-dose-rate intracavitary brachytherapy in cervical cancer patients // Int. J. Radiat. Oncol. Biol. Phys. -2009. - Vol. 74(1). - P. 133-139.

Charra-Brunaud C., Levitchi M., Delannes M. Clinical results of a french prospective study of 3D brachytherapy for cervix carcinoma. Dosimetric // Radiother Oncol. - 2011. - Vol. 99. - P. 57.

Dimopoulos J., Petrow P., Tanderup K. et al. Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group (IV): Basic principles and parameters for MR imaging within the frame of image based adaptive cervix cancer brachytherapy // Radiother Oncol. - 2012. - Vol. 103(1). - P. 113-122.

Gill B.S., Kim H., Houser C.J. et al. MRI-guided high-dose-rate intracavitary brachytherapy for treatment of cervical cancer: the University of Pittsburgh experience // Int. J. Radiat. Oncol. Biol. Phys. - 2015. - Vol. 91(3). - P. 540-547.

Haie-Meder C., Potter R., Van Limbergen E. et al. Recommendations from Gynaecological (GYN) GEC-ESTRO working group (I): concepts and terms in 3D image based 3D treatment planning in cervix cancer brachytherapy with emphasis on MRI assessment of GTV and CTV // J. Radiother Oncol. - 2005. - Vol. 74 (3). -P. 235-245.

Hellebust T.P., Kirisits C., Berger D. et al. Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group: considerations and pitfalls in commissioning and applicator reconstruction in 3D image-based treatment planning of cervix cancer brachytherapy // Radiother Oncol. - 2010. - Vol. 96(2). - P. 153-160.

ICRU report № 89 Prescribing, Recording, and Reporting Brachytherapy For Cancer of the Cervix. Prepared in collaboration with Groupe Europe' en de Curiethe'rapie -European Society for Radiotherapy and Oncology (GEC-ESTRO) (Published June 2016) // Journal of the ICRU. - 2013. - Vol. 13. - № 1. - 274 p.

Ken Yoshida, Hideya Yamazaki, Satoaki Nakamura et al. Role of vaginal pallor reaction in predicting late vaginal stenosis after high-dose-rate brachytherapy in treatmentnaive patients with cervical cancer // Gynecol Oncol. -2015. - Vol. 26(3). - P. 179-184.

Kirchheiner K., Nout R.A., Tanderup K. et al. Manifestation pattern of early-late vaginal morbidity after definitive radiation (chemo)therapy and image-guided adaptive brachytherapy for locally advanced cervical cancer: an analysis from the EMBRACE study // Int. J. Radiat. Oncol. Biol. Phys. - 2014. - Vol. 89(1). - P. 88-95.

Krishnatry R., Patel F.D., Singh P. et al. CT or MRI for image-based brachytherapy in cervical cancer // Jpn J. Clin. Oncol. - 2012. - Vol. 42(4). - P. 309-313.

Lee L.J., Das I.J., Higgins S.A. et al. American Brachytherapy Society consensus guidelines for locally advanced carcinoma of the cervix. Part III: low-dose-rate and pulsed-dose-rate brachytherapy // Brachytherapy. - 2012. - Vol. 11. - P. 53-57.

Lindegaard J.C., Fokdal L.U., Nielsen S.K. et al. MRI-guided adaptive radiotherapy in locally advanced cervical cancer from a Nordic perspective // Acta Oncol. - 2013. - Vol. 52(7). - P. 1510-1519.

Nag S., Cardenes H., Chang S. et al. Proposed guidelines for image-based intracavitary brachytherapy for cervical carcinoma: report from Image-Guided Brachytherapy Working Group // Int. J. Radiat. Oncol. Biol. Phys. - 2004. - Vol. 60. - P. 1160-1172.

Nomden C.N., A.A. de Leeuw, Roesink J.M. et al. Clinical outcome and dosimetric parameters of chemo-radiation including MRI guided adaptive brachytherapy with tandem-ovoid applicators for cervical cancer patients: a single institution experience // Radiother Oncol. - 2013. - Vol. 107. - P. 69-74.

Potter R., Haie-Meder C., Van Limbergen E. et al. GEC ESTRO Working Group. Recommendations from gynaecological (GYN) GEC ESTRO working group (II): concepts and terms in 3D image-based treatment planning in cervix cancer brachytherapy-3D dose volume parameters and aspects of 3D image-based anatomy, radiation physics, radiobiology // J. Radiother Oncol. -2006. - Vol. 78(1). - P. 67-77.

Potter R., Georg P., Dimopoulos J.C. et al. Clinical outcome of protocol based image (MRI) guided adaptive brachytherapy combined with 3D conformal radiotherapy with or without chemotherapy in patients with locally advanced cervical cancer // Radiother Oncol. - 2011. -Vol. 100(1). - P. 116-123.

Rijkmans E.C., Nout R.A. Improved survival of patients with cervical cancer treated with image-guided brachytherapy compared with conventional brachytherapy // Gynecol. Oncol. - 2014. - Vol. 135(2). - P. 231-238.

Tharavichitkul E., Chakrabandhu S., Wanwilairat S. et al. Intermediate-term results of image-guided brachytherapy and high-technology external beam radiotherapy in cervical cancer: Chiang Mai University experience // Gynecol. Oncol. - 2013. - Vol. 130. - P. 81-85.

Viswanathan A.N., Thomadsen B. American Brachytherapy Society Cervical Cancer Recommendations Committee; American Brachytherapy Society. American Brachytherapy Society consensus guidelines for locally advanced carcinoma of the cervix. Part I: general principles // Brachytherapy. - 2012. - Vol. 11(1). - P. 3 - 46.

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

© АННМО «Вопросы онкологии», Copyright (c) 2018